QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 15, 2022 at 10:08 pm
Share
QHSLab, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.350816 million compared to USD 0.455622 million a year ago. Net loss was USD 0.279385 million compared to USD 0.112327 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.
For the six months, sales was USD 0.706146 million compared to USD 0.759957 million a year ago. Net loss was USD 0.469689 million compared to USD 0.199013 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.03 a year ago.
QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company. The Company focuses on enabling primary care physicians (PCPs) to increase their revenues by providing them with tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. The products that the Company provides its physician clients enables them to diagnose and treat patients with chronic diseases The Company is engaged in providing PCPs with the software, training and devices necessary that allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine. Its digital healthcare, clinical decision support and point of care solutions also support non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and are reimbursable to medical practice.